← brief for 2026-09-16 · Slowing decline

GLP-1 receptor agonists, epigenetic aging, and the prospect of pharmacological healthspan extension.

Article No results yet Peer reviewed

Key takeaways

This review discusses how GLP-1 drugs may slow aging of the body’s cells — based on past trials showing fewer heart problems and lower death rates — but it does not report new results, only ties together existing evidence.

Who did this work

Al-Ali D · El Hajj N

Source

Article · PubMed, the drug frontier · 2026 Sep 14
https://pubmed.ncbi.nlm.nih.gov/42735804/